O-desethyl Dapagliflozin
(Synonyms: 达格列净杂质) 目录号 : GC49637An SGLT2 inhibitor and active metabolite of dapagliflozin
Cas No.:864070-37-1
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
O-desethyl Dapagliflozin is an inhibitor of sodium-glucose cotransporter 2 (SGLT2; IC50 = 9.4 nM) and active metabolite of dapagliflozin .1,2 It is selective for SGLT2 over SGLT1 (IC50 = 970 nM).1
1.Xu, B., Feng, Y., Cheng, H., et al.C-aryl glucosides substituted at the 4’-position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetesBioorg. Med. Chem. Lett.21(15)4465-4470(2011) 2.Xu, G., Lv, B., Roberge, J.Y., et al.Design, synthesis, and biological evaluation of deuterated C-aryl glycoside as a potent and long-acting renal sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetesJ. Med. Chem.57(4)1236-1251(2014)
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.6261 mL | 13.1303 mL | 26.2605 mL |
5 mM | 0.5252 mL | 2.6261 mL | 5.2521 mL |
10 mM | 0.2626 mL | 1.313 mL | 2.6261 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。